Cite
Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution.
MLA
Ravichandran, Supriya, et al. “Longitudinal Antibody Repertoire in ‘Mild’ versus ‘Severe’ COVID-19 Patients Reveals Immune Markers Associated with Disease Severity and Resolution.” Science Advances, vol. 7, no. 10, Mar. 2021. EBSCOhost, https://doi.org/10.1126/sciadv.abf2467.
APA
Ravichandran, S., Lee, Y., Grubbs, G., Coyle, E. M., Klenow, L., Akasaka, O., Koga, M., Adachi, E., Saito, M., Nakachi, I., Ogura, T., Baba, R., Ito, M., Kiso, M., Yasuhara, A., Yamada, S., Sakai-Tagawa, Y., Iwatsuki-Horimoto, K., Imai, M., … Khurana, S. (2021). Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution. Science Advances, 7(10). https://doi.org/10.1126/sciadv.abf2467
Chicago
Ravichandran, Supriya, Youri Lee, Gabrielle Grubbs, Elizabeth M Coyle, Laura Klenow, Osamu Akasaka, Michiko Koga, et al. 2021. “Longitudinal Antibody Repertoire in ‘Mild’ versus ‘Severe’ COVID-19 Patients Reveals Immune Markers Associated with Disease Severity and Resolution.” Science Advances 7 (10). doi:10.1126/sciadv.abf2467.